Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ding, Heng ^a   Tsai, Cheguo ^a   Zhou, Fan ^a   Buchy, Philippe ^b   Deubel, Vincent ^b   Zhou, Paul ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS SIALIDASE; ANTISERUM; SIALIDASE; VIRUS ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; VIRUS LIKE AGENT; ANIMAL; ANTIBODY PRODUCTION; BLOOD; CELL LINE; IMMUNOLOGY; INFLUENZA; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PHYSIOLOGY; SEASON; SERODIAGNOSIS; TITRIMETRY; TREATMENT OUTCOME; VIROLOGY; VIRUS ENTRY;

AVES; MUS; ORTHOMYXOVIRIDAE;

ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CELL LINE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE SERA; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; NEURAMINIDASE; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE INFECTIONS; SEASONS; TITRIMETRY; TREATMENT OUTCOME; VIRUS INTERNALIZATION;

EID: 79953061868     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017821     Document Type: Article

References (31)

1. Cos NJ, Subbarao K, (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407-421.
2. WHO Cumulative number of Confirmed Human Cases of Avian Influenza A (H5N1) Reported to WHO. World Health Organization website. Available: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2010_11_19/en/index.html. Accessed 2010 Nov 19.
3. Peiris JSM, de Jong MD, Guan Y, (2007) Avian Influenza Virus (H5N1): a Threat to Human Health. Clin Microbiol Rev 20: 243-267.
4. Monto AS, Ohmit SE, (2009) Seasonal influenza vaccines: evolutions and future trends. Expert Rev Vaccines 8: 383-389.
5. Couch RB, (2008) Seasonal inactivated influenza virus vaccines. Vaccine 26S: D5-D9.
6. Gioia C, Castilletti C, Tempestilli M, Piacentini P, Bordi L, et al. (2008) Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 14: 121-128.
7. Tang JW, Karry LK, Chan PSK, (2008) Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans. J Med Virol 80: 1992-1996.
8. Corti D, Suguitan AL Jr, Pinna D, Silacci C, Fernandez-Rodriguez BM, et al. (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 120: 1663-1673.
9. Tsai CG, Caillet C, Hu HX, Zhou F, Ding H, et al. (2009) Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine 27: 6777-6790.
10. Zhou B, Zhong N, Guan Y, (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357: 1450-1451.
11. Buchy P, Mardy S, Vong S, Toyoda T, Aubin JT, et al. (2007) Influenza A/H5N1 virus infection in humans in Cambodia. J Clin Virol 39: 164-168.
12. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.
13. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D, (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
14. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
15. Garcia JM, Pepin S, Lagarde N, Ma ES, Vogel FR, et al. (2009) Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin. PLoS ONE 4: e7918.
16. Kositanont U, Wongsurakiat P, Pooruk P, Maranetra N, Puthavathana P, (2010) Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients. Viral Immunol 23: 329-334.
17. Sandbulte MR, Jimenez GS, Boon ACM, Smith LR, Treanor JJ, et al. (2007) Crossreactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Medicine 4: e59.
18. Seo SH, Webster RG, (2001) Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 75: 2516-2525.
19. Cheng X, Eisenbraun M, Xu Q, Zhou H, Kulkarni D, et al. (2009) H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines. PLoS One 4: e4436.
20. Alsharifi M, Furuya Y, Bowden TR, Lobigs M, Koskinen A, et al. (2009) Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections. PLoS One 4: e5336.
21. Ichinohe T, Tamura S, Kawaguchi A, Ninomiya A, Imai M, et al. (2007) Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 196: 1313-1320.
22. Kreijtz JHCM, Bodewes R, van der Brand JMA, de Mutsert G, Baas C, et al. (2009) Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine 27: 4983-4989.
23. Gillim-Ross L, Subbarao K, (2007) Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses? PLoS Medicine 4: e91.
24. van Maurik A, Sabarth N, Dacho HS, Brühl P, Schwendinger M, et al. (2010) Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1vaccination. Vaccine 28: 1778-1785.
25. Tumpey TM, Renshaw M, Clements JD, Katz JM, (2001) Mucosal delivery vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 75: 5141-5150.
26. Biddison WE, Shaw S, Nelson DL, (1979) Virus specificity of human influenza virusimmune cytotoxic T cells. J Immunol 122: 660-664.
27. Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, et al. (2004) Recognition of homo- heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol 172: 2453-2460.
28. Lee LY-H, Ha DLA, Simmons C, de Jong MD, Chau NVV, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118: 3478-3490.
29. Bui HH, Peters B, Assarsson E, Mbawuike I, Sette A, (2007) Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci U S A 104: 246-251.
30. Jameson J, Cruz J, Ennis FA, (1998) Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 72: 8682-8689.
31. McMichael AJ, Askonas BA, (1878) Influenza virus-specific T cells in man; induction and properties of the cytotoxic cells. Eur J Immunol 8: 705-711.